The brand name Accutane was discontinued in 2009, but the drug itself, isotretinoin, is still widely prescribed in the United States under several generic names. Roche, the original manufacturer, pulled Accutane from the market for business reasons, not safety concerns. The FDA formally confirmed that the withdrawal was not related to safety or effectiveness. Today, isotretinoin remains the most powerful treatment available for severe acne.
What Replaced the Accutane Brand
When Roche discontinued Accutane in June 2009, three approved generic versions were already on the market. The FDA currently lists these isotretinoin products as available in the U.S.:
- Absorica and Absorica LD
- Amnesteem
- Claravis
- Myorisan
- Zenatane
All of these contain the same active ingredient at the same strengths Accutane came in (10 mg, 20 mg, and 40 mg capsules). When people say they’re “on Accutane,” they almost always mean one of these generics. Dermatologists still casually refer to the drug as Accutane, the way people call all adhesive bandages Band-Aids.
Who Qualifies for a Prescription
Isotretinoin isn’t a first-line acne treatment. Dermatologists typically reserve it for severe nodular acne, the deep, painful cysts that leave scars, or for moderate acne that hasn’t responded to other treatments like antibiotics and topical retinoids. The American Academy of Dermatology also endorses isotretinoin for acne that keeps relapsing after other treatments or acne causing significant psychological distress or scarring.
In practice, many patients who end up on isotretinoin have tried multiple other options for months or years without lasting results. Your dermatologist will assess whether the severity of your acne justifies the monitoring requirements and side effects that come with the drug.
The iPLEDGE Program
Every isotretinoin prescription in the U.S. goes through iPLEDGE, an FDA-mandated safety program designed to prevent pregnancies during treatment. Isotretinoin causes severe birth defects, and this risk is the reason the prescribing process is more involved than for most medications.
Patients, prescribers, and pharmacies all must register in the iPLEDGE system. If you can become pregnant, you’ll need two forms of contraception and regular pregnancy tests. A pregnancy test is required before treatment starts (done in a medical setting), and follow-up tests continue monthly. If you pick up your prescription late and miss the 7-day dispensing window, you’ll need a repeat pregnancy test, though the FDA eliminated the previous rule requiring an additional waiting period before retesting.
For patients who cannot become pregnant, the requirements are lighter. Counseling happens at enrollment, and the FDA removed the requirement for monthly documentation of that counseling. In February 2026, the FDA approved additional modifications to reduce the overall burden on patients and providers while keeping the core safety structure in place. These changes take effect 180 days after approval.
What a Typical Course Looks Like
Isotretinoin treatment is dosed by body weight. A common starting point for severe acne is around 0.5 mg per kg of body weight per day, with the dose gradually increased over the first month toward 1 mg per kg per day as tolerated. For moderate acne, doctors often start lower, around 0.25 to 0.4 mg per kg per day.
The goal is to reach a cumulative dose of 120 to 150 mg per kg over the full course. For most people, this takes roughly five to seven months depending on body weight and how quickly the dose is increased. Some patients, particularly those who relapse, may need higher cumulative doses. Research suggests doses of 220 mg per kg or higher are sometimes necessary for optimal results. Your dermatologist will adjust based on how your skin responds and how well you tolerate side effects.
Blood Work and Monitoring
Before starting isotretinoin, you’ll have baseline blood tests checking liver function, cholesterol and triglyceride levels, a complete blood count, and kidney markers. Isotretinoin can temporarily raise liver enzymes and blood fats, so monitoring catches problems early.
How often you need blood draws depends on your risk level. If you’re young, healthy, and on a lower dose, you’ll likely need a full panel at baseline, another check at one month, and then follow-ups every two to three months. If you’re on a higher dose or have pre-existing conditions affecting your liver or cholesterol, expect monthly or bimonthly blood work until your levels stabilize. Triglycerides get the closest attention: if they climb above 500 mg/dL, your doctor will reduce the dose or pause treatment. Liver enzymes are monitored similarly, with treatment continuing as long as they stay within a reasonable range.
After treatment ends, you’ll have a final check of liver function and lipids. Ongoing monitoring after that is only needed if something was abnormal during therapy.
Common Side Effects
Nearly everyone on isotretinoin experiences some degree of dryness. About half of patients get noticeably dry skin, and roughly 42% develop chapped, cracked lips (called cheilitis). Lip balm and moisturizer become daily essentials. Joint and muscle discomfort is also common: back pain affects about 20% of patients, joint pain around 17%, and general musculoskeletal soreness about 13%.
Most of these side effects are manageable and resolve after treatment ends. Dry eyes can be an issue, especially for contact lens wearers. Nosebleeds, dry nasal passages, and increased sun sensitivity are also typical. Your dermatologist will likely recommend a simple routine of heavy moisturizers, SPF, and artificial tears if needed.
Mental Health and Isotretinoin
The question of whether isotretinoin causes depression has followed the drug for decades, and it remains one of the biggest concerns patients have. The current evidence is reassuring. Large population studies comparing isotretinoin patients to both the general population and acne patients treated with antibiotics have not found an increase in depression or suicide rates. The Royal College of Psychiatrists estimates that fewer than 1 in 10,000 patients experience depression, suicidal thoughts, or psychotic symptoms while on the drug.
Interestingly, suicide is reported more commonly in people with acne who have never taken isotretinoin than in those who have. Severe acne itself carries a significant mental health burden, and clearing the skin often improves mood and quality of life. A recent study of patients who attempted suicide while on isotretinoin found they were more likely to have pre-existing risk factors like a personal or family history of mental illness, making it difficult to attribute the event to the medication. There is no evidence that people with a history of depression face a higher risk of mood changes on isotretinoin.
That said, mood changes do occur in a small number of patients. An estimated 1 in 1,000 to 1 in 10,000 people may notice tearfulness, low mood, anxiety, or agitation. Staying aware of changes in how you feel and keeping your prescriber informed is a reasonable precaution.